iRhythm Technologies 

$69.78
20
-$0.2-0.28% 今天

統計

當日最高
70.47
當日最低
69.47
52週最高
124.12
52週最低
60.88
成交量
47,666
平均成交量
479,196
市值
2.21B
市盈率
-
股息收益率
-
股息
-

即將到來

收益

31Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
-1.47
-1.12
-0.78
-0.43
預期每股收益
-0.570788
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 IRTC 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

118.67$平均價格目標
最高估價為 $145。
來自過去 6 個月內的 9 個評級。這不是投資建議。
買入
100%
持有
0%
賣出
0%

關於

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Show more...
首席執行官
Kevin King
員工
2000
國家
US
ISIN
US4500561067

上市公司